| Metric | შპს SIAPHARM | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾3.9m₾4.5m | ₾1.06bn₾1.08bn |
| Revenue growth | -15.0% | -1.3% |
| Profitability | ||
| EBITDA | ₾379k₾12k | — |
| EBITDA margin | 9.8%0.3% | — |
| Net profit | ₾157k-₾63k | ₾337.3m₾545.7m |
| Net margin | 4.1%-1.4% | 31.8%50.7% |
| Balance sheet | ||
| Total assets | ₾1.7m₾1.8m | ₾22.40bn₾18.26bn |
| Total equity | ₾368k₾212k | ₾2.83bn₾2.48bn |
| ROE | 42.6%-30.0% | 11.9%22.0% |